Our antibodies have a neutralising effect when tested against the live virus SARS-CoV-2 variant 501Y.V2, also known as the ‘SA variant’. This was independently verified in February 2021 by the Africa Health Research Institute (AHRI) at the University of KwaZulu-Natal, South Africa. Our Covid-19 antibody project has been running since February 2020. Read more here.

In January 2021, Glasgow University’s Centre for Virus Research confirmed exactly which of the antibodies we produced have a neutralising effect on Covid-19 in human cells.  This follows their independent validation in June 2020 that the serum we had produced did indeed neutralise SARS-CoV-2. Our Covid-19 antibody project has been running since February 2020. Read more here.

Afrobodies Chief Scientific Officer, Dr Peter Durcan, was interviewed by BBC World Service’s Focus on Africa radio programme about their recent Covid-19 breakthrough.

We draw on the unique properties of the immune systems of our happy, healthy alpacas to create custom antibodies that are heat stable and robust, yet sensitive.